![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bespak | LSE:BPK | London | Ordinary Share | GB0000946276 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 667.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number:0159C Bespak PLC 26 April 2006 For immediate release 26 April 2006 Bespak plc Board Changes Bespak plc (LSE: BPK), a leader in specialty medical devices, is pleased to announce the appointment of two new non-executive directors, Jim Dick and Chris Banks to the Board of Bespak with immediate effect. Jim, 53, has been President of Smith & Nephew Wound Management, and a member of the Smith & Nephew Group Executive Committee, since 1999. Jim will retire from Smith & Nephew plc at the end of June this year. Throughout his career Jim has gained a large amount of experience in international business, innovation and change management. Chris, 56, has considerable experience of financial matters in international growth-oriented companies. He was finance director at the BIS Group from 1985 to 1991 and finance director at cmg plc from 1992 to 2000. He is currently senior non-executive director at Detica Group plc and The Innovation Group plc. Bespak also announces today the resignation of Adrian Auer as a non-executive director. There are no other details to be disclosed under paragraph 6.F.2. of the Listing Rules. John Robinson, Bespak's Chairman, commented: " I would like to extend the thanks of the Company and the Board to Adrian who has resigned due to his other commitments. I am delighted to welcome Jim and Chris to the Board. Jim will become a member of our Remuneration Committee in the next few months and his healthcare industry experience will be of immense benefit to the Company. Chris will replace Adrian as Chairman of our Audit Committee where his experience of corporate finance will also be of immense benefit." For further information please call: Bespak plc John Robinson - Chairman +44 (0) 20 7960 6320 Mark Throdahl - Chief Executive +44 (0) 20 1908 552 600 Martin Hopcroft - Group Finance Director Buchanan Communications +44 (0) 20 7466 5000 Tim Thompson / Mark Court / Mary-Jane Johnson Notes for Editors: About Bespak plc Bespak, a leader in specialty medical devices, develops delivery systems for the pharmaceutical industry and disposable airway management products for critical care settings. Bespak's product range includes metered dose and dry powder inhalers, actuators, inflation valves, disposable face masks, breathing circuits and laryngeal tubes.. The group, which has facilities in King's Lynn and Milton Keynes in the UK and Indianapolis and Kent, Ohio in the US, is quoted on the Official list of the London Stock Exchange (LSE: BPK). For more information, please visit www.bespak.com. This information is provided by RNS The company news service from the London Stock Exchange END BOASEUFFMSMSEEL
1 Year Bespak Chart |
1 Month Bespak Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions